Stockreport

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed [MSNBC.com]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF In this articleAstraZenecaThe respiratory treatment tozorakimab, reduced flare-ups of chronic obstructive pulmonary disease (COPD) in both former smokers and in the over [Read more]